MesoTV Podcast: Conversations Impacting the Mesothelioma Community
Ein Podcast von Mesothelioma Applied Research Foundation
39 Folgen
-
MesoTV: The surgical approach to meso and how genetics impact treatment
Vom: 14.12.2021 -
Radiation and immunotherapy: emerging mechanisms of synergy w/ Dr. Breen from Mayo Clinic
Vom: 9.11.2021 -
Chemotherapy + immunotherapy, another positive step in mesothelioma treatment
Vom: 9.11.2021 -
”Does staging matter in mesothelioma” with Dr. James Stevenson of the Cleveland Clinic
Vom: 1.10.2021 -
Pneumonitis in immunotherapy-treated mesothelioma patients
Vom: 30.9.2021 -
Peritoneal mesothelioma surgery and treatment at the National Cancer Institute
Vom: 30.9.2021 -
Toxicities, side-effects, from immunotherapy for treatment of mesothelioma
Vom: 13.7.2021 -
CLINICAL TRIAL: Engineered T-cell therapy (TC-210, gavo-cel) for mesothelioma
Vom: 11.6.2021 -
CLINICAL TRIAL: Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
Vom: 25.5.2021 -
Current trends in mesothelioma treatment - discussion by thought-leaders in this disease
Vom: 20.5.2021 -
Pain management for mesothelioma patients from a multi-disciplinary perspective
Vom: 18.5.2021 -
Discussion of mesothelioma patients who underwent an EPP (extrapleural pneumonectomy - lung removal)
Vom: 3.2.2021 -
Clinical trial assessing the addition of IMRT to pemetrexed (Alimta)/platinum based therapy
Vom: 26.1.2021 -
Vaccination Considerations for Mesothelioma Patients
Vom: 13.1.2021 -
Dr. Paul Sugarbaker discusses HIPEC in peritoneal mesothelioma
Vom: 11.1.2021 -
Mesothelioma Patients Discuss "Chemo Brain"
Vom: 7.1.2021 -
Inherited Genetics and Mesothelioma
Vom: 6.1.2021 -
Life After Mesothelioma Treatment Community Panel
Vom: 6.1.2021 -
FDA's Expanded Access and Compassionate Use Rules' Impact on Mesothelioma Treatment
Vom: 6.1.2021
The Mesothelioma Applied Research Foundation developed MesoTV in response to the need to cancel our annual International Symposium on Malignant Mesothelioma. In our first season we covered a number of topics, many focused on the immediate effects of Covid-19 on mesothelioma treatment. In our second season and beyond, we focus on more traditional topics such as advances in treatment, mesothelioma science, the patient and caregiver experience and quality of life. The Mesothelioma Applied Research Foundation is the only nonprofit charity organization dedicated to ending mesothelioma, and the suffering caused by this cancer, by: funding research to improve treatment options; providing treatment support and education for patients and their families; and advocating for federal funding of research.
